Many studies are underway to describe the human microbiome, I will describe some of the methods used that combine phylogenetic trees and abundance data from high throughput sequencing and new microarray techniques. In particular various `particular metrics' have shown useful in coming to conclusions about explanatory clinical or contingent variables in such studies. This talk contains joint work with PJ McMurdie, as well as David Relman's lab and Alfred Sporman at Stanford.